OVERSEA CHINESE BANKING Corp Ltd Lowers Holdings in Agilent Technologies, Inc. $A

OVERSEA CHINESE BANKING Corp Ltd lessened its stake in Agilent Technologies, Inc. (NYSE:A) by 1.7% in the 2nd quarter, Holdings Channel.com reports. The firm owned 282,685 shares of the medical research company’s stock after selling 4,853 shares during the quarter. Agilent Technologies makes up 0.9% of OVERSEA CHINESE BANKING Corp Ltd’s holdings, making the stock its 24th largest holding. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Agilent Technologies were worth $33,360,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Verdence Capital Advisors LLC raised its position in shares of Agilent Technologies by 5.0% in the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock worth $215,000 after purchasing an additional 86 shares during the last quarter. Valeo Financial Advisors LLC raised its position in Agilent Technologies by 3.0% in the 1st quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company’s stock worth $403,000 after buying an additional 102 shares during the last quarter. Cary Street Partners Financial LLC raised its position in Agilent Technologies by 2.9% in the 1st quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock worth $431,000 after buying an additional 103 shares during the last quarter. Bartlett & CO. Wealth Management LLC raised its position in Agilent Technologies by 5.1% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company’s stock worth $281,000 after buying an additional 116 shares during the last quarter. Finally, Stratos Wealth Partners LTD. raised its position in Agilent Technologies by 0.3% in the 1st quarter. Stratos Wealth Partners LTD. now owns 41,334 shares of the medical research company’s stock worth $4,835,000 after buying an additional 124 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Robert W. Baird increased their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, August 28th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price objective on the stock. Evercore ISI increased their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research report on Tuesday, October 7th. Finally, TD Cowen increased their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $149.62.

Agilent Technologies Trading Up 0.4%

Agilent Technologies stock opened at $148.03 on Monday. The business has a 50-day simple moving average of $130.39 and a two-hundred day simple moving average of $119.43. The company has a market cap of $41.97 billion, a P/E ratio of 34.75, a P/E/G ratio of 4.83 and a beta of 1.26. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were paid a dividend of $0.248 per share. The ex-dividend date was Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.